Island Pharmaceuticals (ASX:ILA) has entered a strategic research collaboration with the Burnet Institute to expand the development potential of its antiviral drug portfolio and target a broader range of global viral threats.
Latest Video
New Stories
-
Open letter calls for ministerial action on access to continuous glucose monitoring devices
March 30, 2026 - - Latest News -
New treatment milestone offers fresh hope for Australians living with CIDP
March 30, 2026 - - Latest News -
Government expands access to cancer therapy but holds short on pan-tumour listing
March 30, 2026 - - Latest News -
Breathing easy in an ageing Asia-Pacific means fixing a neglected health crisis
March 30, 2026 - - Latest News -
A new chapter for Juvenile Arthritis Foundation Australia as it continues search for new leadership
March 27, 2026 - - Latest News -
The 'Dispatched' Week in Review' Podcast - 27 March
March 27, 2026 - - Podcast -
This is the not so quiet demand and doctrine of rationed health care
March 27, 2026 - - Latest News
